Literature DB >> 4596507

Immunofluorescent localization of antihemophilic factor antigen and fibrinogen in human renal diseases.

J R Hoyer, A F Michael, L W Hoyer.   

Abstract

Tissue localization of antihemophilic factor (AHF, factor VIII) antigen and fibrinogen by immunofluorescent microscopy was determined in 146 specimens of normal and diseased kidneys. AHF antigen was present in the endothelial cells of glomeruli, peritubular capillaries, arteries, and veins of normal kidneys; a distribution similar to that in other tissues. In scleroderma and malignant hypertension, deposition of AHF antigen and fibrinogen was limited to the markedly thickened endothelial layers of arteries. More extensive intense deposition of both AHF antigen and fibrinogen in glomeruli and in arterial walls were present in hyperacute renal homograft rejection, hemolyticuremic syndrome, postpartum renal failure, and in some cases of acute homograft rejection. In contrast, deposition of fibrinogen was observed in glomerular epithelial cresents in severe proliferative glomerulonephritis, but AHF deposition was not present in these lesions. Glomerular deposition of fibrinogen without increased AHF standing was also detected in renal tissue from patients with anaphylactoid purpura nephritis and in recurrent macroscopic hematuria with focal glomerulonephritis. Increased staining of peritubular capillaries with anti-AHF was seen in diseased kidneys irrespective of etiology. Immunofluorescent localization of AHF, a participant in the intrinsic coagulation pathway, offers a new way by which to analyze the mechanisms responsible for fibrinogen deposition in disease.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4596507      PMCID: PMC302626          DOI: 10.1172/JCI107686

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury.

Authors:  W E Braun; J P Merrill
Journal:  N Engl J Med       Date:  1968-06-20       Impact factor: 91.245

2.  An immunofluorescent study of pathogenic mechanisms in glomerular diseases.

Authors:  R T McCluskey; P Vassalli; G Gallo; D S Baldwin
Journal:  N Engl J Med       Date:  1966-03-31       Impact factor: 91.245

3.  Activation of Hageman factor by collagen.

Authors:  G D Wilner; H L Nossel; E C LeRoy
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

4.  Clotting changes, including disseminated intravascular coagulation, during rapid renal-homograft rejection.

Authors:  T E Starzl; H J Boehmig; H Amemiya; C B Wilson; F J Dixon; G R Giles; K M Simpson; C G Halgrimson
Journal:  N Engl J Med       Date:  1970-08-20       Impact factor: 91.245

5.  Split products of fibrin in human renal disease.

Authors:  E R Stiehm; C W Trygstad
Journal:  Am J Med       Date:  1969-05       Impact factor: 4.965

6.  Anaphylactoid purpura. II. Immunofluorescent and electron microscopic studies of the glomerular lesions.

Authors:  R E Urizar; A Michael; S Sisson; R L Vernier
Journal:  Lab Invest       Date:  1968-10       Impact factor: 5.662

7.  Fibrinogen deposition in acute renal failure.

Authors:  D Koffler; F Paronetto
Journal:  Am J Pathol       Date:  1966-08       Impact factor: 4.307

8.  Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. II. Acute, subacute, and chronic glomerulonephritis.

Authors:  D Koffler; F Paronetto
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

9.  Acute poststreptococcal glomerulonephritis: immune deposit disease.

Authors:  A F Michael; K N Drummond; R A Good; R L Vernier
Journal:  J Clin Invest       Date:  1966-02       Impact factor: 14.808

10.  Localization of immunological complexes fixing beta1C (C3) in germinal centers of lymph nodes.

Authors:  K J Gajl-Peczalska; A J Fish; H J Meuwissen; D Frommel; R A Good
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

View more
  15 in total

1.  The participation of macrophages, glomerular procoagulant activity, and factor VIII in glomerular fibrin deposition. Studies on anti-GBM antibody-induced glomerulonephritis in rabbits.

Authors:  P G Tipping; S R Holdsworth
Journal:  Am J Pathol       Date:  1986-07       Impact factor: 4.307

2.  Glomerular procoagulant activity in human proliferative glomerulonephritis.

Authors:  P G Tipping; J P Dowling; S R Holdsworth
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Phenotypic heterogeneity of vascular endothelial cells in the human kidney.

Authors:  T Kinjo; M Takashi; K Miyake; H Nagura
Journal:  Cell Tissue Res       Date:  1989-04       Impact factor: 5.249

4.  Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits.

Authors:  P G Tipping; M G Lowe; S R Holdsworth
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

5.  Acute crescentic glomerulonephritis developing during warfarin therapy.

Authors:  J H Turney; J Michael; D Adu
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

6.  Urinary excretion of factor VIII after renal transplantation.

Authors:  Z M Ruggeri; Y B Gordon; N Ardaillou; M J Larrieu; A Tarantino; R Coppola; C Ponticelli; P M Mannucci
Journal:  Br Med J       Date:  1979-02-03

7.  Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.

Authors:  G J Busch; K Kobayashi; N K Hollenberg; A G Birtch; R W Colman
Journal:  Am J Pathol       Date:  1975-07       Impact factor: 4.307

8.  Urinary tissue factor in glomerulonephritis: a potential marker of glomerular injury?

Authors:  B A Lwaleed; P S Bass; M Chisholm; J L Francis
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

9.  Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.

Authors:  S R Holdsworth; P G Tipping
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

Review 10.  Malignant or accelerated hypertension.

Authors:  N D Vaziri
Journal:  West J Med       Date:  1984-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.